SYRE – spyre therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

SYRE

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

9/26

07:36 am

syre

Rating for SYRE

Low Report

Rating for SYRE

Report

9/26

07:36 am

syre

Rating for SYRE

Low Report

Rating for SYRE

Report

9/26

04:34 am

syre

Spyre Therapeutics initiated with a Buy at Deutsche Bank

Low Report

Spyre Therapeutics initiated with a Buy at Deutsche Bank

Report

9/26

04:34 am

syre

Spyre Therapeutics initiated with a Buy at Deutsche Bank

Low Report

Spyre Therapeutics initiated with a Buy at Deutsche Bank

Report

9/16

08:07 am

syre

Spyre Therapeutics (NASDAQ:SYRE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $70.00 price target on the stock.

Low Report

Spyre Therapeutics (NASDAQ:SYRE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $70.00 price target on the stock.

Report

9/16

06:41 am

syre

Rating for SYRE

Low Report

Rating for SYRE

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.